-
Alfacalcidol
Nomen Iaponica:
Pharmacopoeia: BP/EP
CAS Number: 41294-56-8
CDMF No.: Y20180000715
Formulae hypotheticae: C27H44O2
Pondus hypotheticum: 400.6 g/mol
Indicationes clinicae: Osteoporosis, insufficientiae renum chronicae, hypoparathyroidismi, Vitaminum D-resistentes rickets, Osteomalacia
-
Calcifediol
Nomen Iaponica:カルシフェジ オール
Pharmacopoeia:BP/EP/USP
CAS Number:63283-36-3
CDMF No.:Ut profiteretur
Formulae hypotheticae:C27H46O2
M. Pondus:418.7 g/mol
Orci Indicationes:Osteoporosis, Rickets, Osteomalacia
-
Calcipotriene
Nomen Iaponica:
Pharmacopoeia: BP/EP/JP
CAS Number: 147657-22-5
CDMF No.: Y202000001036
Formulae hypotheticae: C27H40O3•H2O
Pondus hypotheticum: 430.600 g/mol
Indicationes clinicae: Psoriasis Vulgaris
-
Calcitriolum
Nomen Iaponica:
Pharmacopoeia: BP/EP/USP
CAS Number: 32222-06-3
CDMF No.: Y2021000028
Formulae hypotheticae: C27H42O2
Pondus hypotheticum: 416.600 g/mol
Indicationes clinicae: Rickets, Osteoporosis, Hypoparathyroidismus, Osteodystrophy renalis, Osteomalacia
-
Doxercalciferol
Nomen Iaponica:
Pharmacopoeia: USP
CAS Number: 54573-75-0
CDMF No.: Y20180001141
Formulae hypotheticae: C28H44O2
Molecular pondus: 412.600 g/mol
Indicationes clinicae: hyperparathyroidism secundae
-
Eldecalcitol
Nomen Iaponica:
Pharmacopoeia: Enterprise vexillum
CAS Number: 104121-92-8
CDMF No.: Y20210000737
Formulae hypotheticae: C30H50O5
Pondus hypotheticum: 490.700 g/mol
Indicationes clinicae: Osteoporosis
-
Ketorolac tromethamine
Nomen Iaponica:
Pharmacopoeia: ChP/USP
CAS Number: 74103-07-4
CDMF No.: Y20210000317
Formulae hypotheticae: C19H24N2O6
Pondus hypotheticum: 376.400 g/mol
Indicationes clinicae: Brevis terminus (usque ad 5 dies in adultis), administratio doloris modice gravis acuti, qui analgesiam requirit in gradu opioide.
-
Acidum Thioctic Trometamol
Synonym: Acidum Lipoicum tromethamine
Nomen Iaponica:
Pharmacopoeia: /
CAS Number: 62-46-4
CDMF No.: Y2000000812
Formulae hypotheticae: C8H14O2S2·C4H11NO3
Pondus hypotheticum: 327.460 g/mol
Acta indicia: Vasculares accentus in aegris cum diabete
-
Maxacalcitol
Nomen Iaponica:
Pharmacopoeia: JP
CAS Number: 103909-75-7
CDMF No.: Ut sit relatus
Formulae hypotheticae: C26H42O4
Pondus hypotheticum: 418.618 g/mol
Indicationes clinicae: hyperparathyroidismi secundae, Psoriasis
-
Paricalcitolum
Nomen Iaponica:
Pharmacopoeia: USP
CAS Number: 131918-61-1
CDMF No.: Ut sit relatus
Formulae hypotheticae: C27H44O3
Pondus hypotheticum: 416.646 g/mol
Indicationes clinicae: hyperparathyroidism secundae
-
Regadenoson
Nomen Iaponica:
Pharmacopoeia: /
CAS Number: 313348-27-5
USDMF No.: 036679
CDMF No.: Y2000000551
Formulae hypotheticae: C15H18N8O5
Pondus hypotheticum: 390.350 g/mol
Indicationes clinicae: Accentus pharmacologicus agentis indicatur propter perfusionem radionuclidis myocardialis imaginandi (MPI) in aegris non valentibus adaequatam exercitium accentus subire.
-
Tacalcitolum monohydratorum
Nomen Iaponica:
Pharmacopoeia: BP/EP/JP
CAS Number: 93129-94-3
CDMF No.: Y20180001179
Formulae hypotheticae: C27H44O3•H2O
Pondus hypotheticum: 434.661 g/mol
Indicationes clinicae: Psoriasis Vulgaris
